The Immune Landscape of Cancer

Vésteinn Thórsson , David L. Gibbs , Scott D. Brown , Vésteinn Thórsson , David L. Gibbs , Scott D. Brown , Denise M. Wolf , Dante S. Bortone , Tai-Hsien Ou Yang , Eduard Porta‐Pardo , Galen F. Gao , Christopher Plaisier , James A. Eddy , Elad Ziv , Aedín C. Culhane , Evan Paull , I.K. Ashok Sivakumar , Andrew J. Gentles , Raunaq Malhotra , Farshad Farshidfar , Antonio Colaprico , Joel S. Parker , Lisle E. Mose , Nam S. Vo , Jianfang Liu , Yuexin Liu , Janet S. Rader , Varsha Dhankani , Sheila M. Reynolds , Reanne Bowlby , Andrea Califano , Andrew D. Cherniack , Dimitris Anastassiou , Davide Bedognetti , Younes Mokrab , Aaron M. Newman , Arvind Rao , Ken Chen , Alexander Krasnitz , Hai Hu , Tathiane M. Malta , Houtan Noushmehr , Chandra Sekhar Pedamallu , Susan Bullman , Akinyemi I. Ojesina , Andrew Lamb , Wanding Zhou , Hui Shen , Toni K. Choueiri , John N. Weinstein , Justin Guinney , Joel Saltz , Robert A. Holt , Charles S. Rabkin , Alexander J. Lazar , Jonathan S. Serody , Elizabeth G. Demicco , Mary L. Disis , Benjamin G. Vincent , Ilya Shmulevich , Rory Johnson , John A. Demchok , Ina Felau , Melpomeni Kasapi , Martin L. Ferguson , Carolyn M. Hutter , Heidi J. Sofia , Roy Tarnuzzer , Zhining Wang , Liming Yang , Jean C. Zenklusen , Jiashan Zhang , Sudha Chudamani , Jia Liu , Laxmi Lolla , Rashi Naresh , Todd Pihl , Qiang Sun , Yunhu Wan , Ye Wu , Juok Cho , Timothy Defreitas , Scott Frazer , Nils Gehlenborg , Gad Getz , David I. Heiman , Seungchan Kim , Michael S. Lawrence , Pei Lin , Thomas J. Giordano , Michael S. Noble , Gordon Saksena , Doug Voet , Hailei Zhang , Brady Bernard , Nyasha Chambwe , Varsha Dhankani , Theo Knijnenburg , Roger Kramer , Kalle Leinonen , Yuexin Liu , Michael Miller , Sheila M. Reynolds
2018 Immunity 5,827 citations

Abstract

We performed an extensive immunogenomic analysis of more than 10,000 tumors comprising 33 diverse cancer types by utilizing data compiled by TCGA. Across cancer types, we identified six immune subtypes-wound healing, IFN-γ dominant, inflammatory, lymphocyte depleted, immunologically quiet, and TGF-β dominant-characterized by differences in macrophage or lymphocyte signatures, Th1:Th2 cell ratio, extent of intratumoral heterogeneity, aneuploidy, extent of neoantigen load, overall cell proliferation, expression of immunomodulatory genes, and prognosis. Specific driver mutations correlated with lower (CTNNB1, NRAS, or IDH1) or higher (BRAF, TP53, or CASP8) leukocyte levels across all cancers. Multiple control modalities of the intracellular and extracellular networks (transcription, microRNAs, copy number, and epigenetic processes) were involved in tumor-immune cell interactions, both across and within immune subtypes. Our immunogenomics pipeline to characterize these heterogeneous tumors and the resulting data are intended to serve as a resource for future targeted studies to further advance the field.

Keywords

BiologyImmune systemNeuroblastoma RAS viral oncogene homologEpigeneticsFOXP3Cancer researchImmunologyMelanomaCancerEpigenomeKRASGeneGeneticsGene expressionDNA methylationColorectal cancer

MeSH Terms

AdolescentAdultAgedAged80 and overChildFemaleGenomicsHumansInterferon-gammaMacrophagesMaleMiddle AgedNeoplasmsPrognosisTh1-Th2 BalanceTransforming Growth Factor betaWound HealingYoung Adult

Affiliated Institutions

Related Publications

Publication Info

Year
2018
Type
article
Volume
48
Issue
4
Pages
812-830.e14
Citations
5827
Access
Closed

Social Impact

Altmetric

Social media, news, blog, policy document mentions

Citation Metrics

5827
OpenAlex
228
Influential
4383
CrossRef

Cite This

Vésteinn Thórsson, David L. Gibbs, Scott D. Brown et al. (2018). The Immune Landscape of Cancer. Immunity , 48 (4) , 812-830.e14. https://doi.org/10.1016/j.immuni.2018.03.023

Identifiers

DOI
10.1016/j.immuni.2018.03.023
PMID
29628290
PMCID
PMC5982584

Data Quality

Data completeness: 90%